Iradimed (IRMD) Short-term Investments (2013 - 2022)

Iradimed (IRMD) has reported Short-term Investments for 10 consecutive years, with $500090.0 the latest figure, recorded in Q1 2022.

• On a quarterly basis, Short-term Investments fell 73.72% year-over-year to $500090.0 in Q1 2022; TTM through Mar 2022 was $500090.0, a 73.72% decrease from a year earlier, with the FY2021 full-year figure at $501855.0, down 73.72% from the prior year.
• Short-term Investments was $500090.0 for Q1 2022 at Iradimed, roughly flat from $501855.0 in the prior quarter.
• Over five years, Short-term Investments peaked at $8.2 million in Q2 2018 and troughed at $500090.0 in Q1 2022.
• A 5-year average of $3.6 million and a median of $2.8 million in 2019 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments grew 16.34% in 2018 and tumbled 73.72% in 2022, its largest moves.
• Over 5 years, Short-term Investments stood at $6.3 million in 2018, then sank by 56.4% to $2.8 million in 2019, then sank by 31.03% to $1.9 million in 2020, then slumped by 73.72% to $501855.0 in 2021, then declined by 0.35% to $500090.0 in 2022.
• The last three Short-term Investments figures came in at $500090.0 (Q1 2022), $501855.0 (Q4 2021), and $945066.0 (Q3 2021), per Business Quant data.